Showing results (331-340 of 419) with videos related to

Sort By:
Pageof 42
Nanotoxicology|September 14, 2016
Oral intake of added titanium dioxide and its nanofraction from food products, food supplements and toothpaste by the Dutch populationCathy Rompelberg, Minne B Heringa, Gerda van Donkersgoed, et al.
Integrative Medicine Research|September 25, 2025
The efficacy and safety of multiple acupuncture therapies in primary insomnia: A Bayesian network meta-analysisLiguo Liu, Yiming Chen, Minne Tian, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|May 1, 1994
Comparison of a semiquantitative and a quantitative method for assessing vertebral fractures in osteoporosisG Leidig-Bruckner, H K Genant, H W Minne, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 13, 2018
NKG2D Immunoligand rG7S-MICA Enhances NK Cell-mediated Immunosurveillance in Colorectal CarcinomaTong Wang, Fumou Sun, Yang Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
CD4+ Th2 cell recognition of HLA-DR-restricted epitopes derived from CAMEL: a tumor antigen translated in an alternative open reading frameElisabeth H Slager, Martina Borghi, Carolien E van der Minne, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|November 29, 2005
Prospective identification of postmenopausal osteoporotic women at high vertebral fracture risk by radiography, bone densitometry, quantitative ultrasound, and laboratory findings: results from the PIOS studyMaren Gesina Glüer, Helmut W Minne, Claus-Christian Glüer, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|February 9, 2000
Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study GroupJ Reginster, H W Minne, O H Sorensen, et al.
Pageof 42